BCRWA @ The 64th ASH Annual Meeting & Exposition 2022

Management of indolent B-cell Lymphomas: A review of approved and emerging targeted therapies

Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

Blood, Sweat and Tears of Joy 2022

Emerging therapies for the management of Richter transformation

Practical management of chronic lymphocytic leukemia with acalabrutinib

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study

Ibrutinib improves survival compared to chemotherapy in mantle cell lymphoma with central nervous system relapse

Patient Story: Adam Carty

WATCH: Professor Chan Cheah @ Blood, Sweat and Tears of Joy